{"id":153917,"name":"SUMITOMO PHARMA CO., LTD. (FORMERLY SUNOVION PHARMACEUTICALS, INC.)","slug":"sumitomo-pharma-co-ltd-formerly-sunovion-pharmaceuticals-inc","state":"MA","country":"United States of America","description":"Pharmaceutical company","totalSpending":1266000,"filings":26,"yearlySpending":[{"year":2018,"income":204000},{"year":2019,"income":204000},{"year":2020,"income":204000},{"year":2021,"income":204000},{"year":2022,"income":200000},{"year":2023,"income":200000},{"year":2024,"income":50000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"}],"firms":["JEFFREY J. KIMBELL & ASSOCIATES, INC."],"lobbyists":["JEFFREY KIMBELL","JODIE LOCKHART","JOHN HERZOG","KEITH STUDDARD","KENNETH HODGE","JOHN RAY","DAVID RUDLOFF","KELSEY CARLSON"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Office of Management & Budget (OMB)"],"sampleDescriptions":["General Health Care Issues and Reimbursement","Mental Health issues","Issues related to Medicare Part D","Mental Health issues","Issues related to Medicare Part D"]}